Lipocine Inc. (LPCN) Social Stream
LIPOCINE INC (LPCN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LPCN.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
LPCN's average price target has moved down $0.83 over the prior 20 months.
Over the past 44 weeks, LPCN's average upside potential has been 576.05%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LPCN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 17 months, LPCN's average broker recommendation rating improved by 0.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- LPCN has a greater average analyst price target than 14.97% of all US stocks.
- In terms of how LIPOCINE INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 674.03% of that group.
- In terms of how LIPOCINE INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 28.24% of that group.
- LPCN has a lower variance in analysts' estimates than -469.86% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LIPOCINE INC are VSTM, RGLS, and KPTI.
View All Top Stocks by Price Target
What is the outlook for LPCN? Use POWR Ratings for clearer insight into price direction.